The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis.
Meta-analysis
Osteoporosis
Prevalence
Systematic review
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
17 Oct 2021
17 Oct 2021
Historique:
received:
26
08
2021
accepted:
04
10
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
28
1
2022
Statut:
epublish
Résumé
Osteoporosis affects all sections of society, including families with people affected by osteoporosis, government agencies and medical institutes in various fields. For example, it involves the patient and his/her family members, and government agencies in terms of the cost of treatment and medical care. Providing a comprehensive picture of the prevalence of osteoporosis globally is important for health policymakers to make appropriate decisions. Therefore, this study was conducted to investigate the prevalence of osteoporosis worldwide. A systematic review and meta-analysis were conducted in accordance with the PRISMA criteria. The PubMed, Science Direct, Web of Science, Scopus, Magiran, and Google Scholar databases were searched with no lower time limit up till 26 August 2020. The heterogeneity of the studies was measured using the I After following the systematic review processes, 86 studies were selected for meta-analysis. The sample size of the study was 103,334,579 people in the age range of 15-105 years. Using meta-analysis, the prevalence of osteoporosis in the world was reported to be 18.3 (95% CI 16.2-20.7). Based on 70 studies and sample size of 800,457 women, and heterogenicity I According to the medical, economic, and social burden of osteoporosis, providing a robust and comprehensive estimate of the prevalence of osteoporosis in the world can facilitate decisions in health system planning and policymaking, including an overview of the current and outlook for the future; provide the necessary facilities for the treatment of people with osteoporosis; reduce the severe risks that lead to death by preventing fractures; and, finally, monitor the overall state of osteoporosis in the world. This study is the first to report a structured review and meta-analysis of the prevalence of osteoporosis worldwide.
Sections du résumé
BACKGROUND
BACKGROUND
Osteoporosis affects all sections of society, including families with people affected by osteoporosis, government agencies and medical institutes in various fields. For example, it involves the patient and his/her family members, and government agencies in terms of the cost of treatment and medical care. Providing a comprehensive picture of the prevalence of osteoporosis globally is important for health policymakers to make appropriate decisions. Therefore, this study was conducted to investigate the prevalence of osteoporosis worldwide.
METHODS
METHODS
A systematic review and meta-analysis were conducted in accordance with the PRISMA criteria. The PubMed, Science Direct, Web of Science, Scopus, Magiran, and Google Scholar databases were searched with no lower time limit up till 26 August 2020. The heterogeneity of the studies was measured using the I
RESULTS
RESULTS
After following the systematic review processes, 86 studies were selected for meta-analysis. The sample size of the study was 103,334,579 people in the age range of 15-105 years. Using meta-analysis, the prevalence of osteoporosis in the world was reported to be 18.3 (95% CI 16.2-20.7). Based on 70 studies and sample size of 800,457 women, and heterogenicity I
CONCLUSION
CONCLUSIONS
According to the medical, economic, and social burden of osteoporosis, providing a robust and comprehensive estimate of the prevalence of osteoporosis in the world can facilitate decisions in health system planning and policymaking, including an overview of the current and outlook for the future; provide the necessary facilities for the treatment of people with osteoporosis; reduce the severe risks that lead to death by preventing fractures; and, finally, monitor the overall state of osteoporosis in the world. This study is the first to report a structured review and meta-analysis of the prevalence of osteoporosis worldwide.
Identifiants
pubmed: 34657598
doi: 10.1186/s13018-021-02772-0
pii: 10.1186/s13018-021-02772-0
pmc: PMC8522202
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
609Subventions
Organisme : Deputy for Research and Technology, Kermanshah University of Medical Sciences
ID : 3010862
Informations de copyright
© 2021. The Author(s).
Références
Arch Osteoporos. 2013;8:116
pubmed: 23371477
Head Face Med. 2020 Oct 6;16(1):22
pubmed: 33023617
Spine (Phila Pa 1976). 2016 Feb;41(4):328-36
pubmed: 26866957
Singapore Med J. 2009 Jan;50(1):20-8
pubmed: 19224080
Curr Osteoporos Rep. 2012 Dec;10(4):245-7
pubmed: 22898971
JNMA J Nepal Med Assoc. 2019 Nov-Dec;57(220):393-497
pubmed: 32335647
Indian J Endocrinol Metab. 2018 Jan-Feb;22(1):67-73
pubmed: 29535940
Climacteric. 2017 Apr;20(2):157-163
pubmed: 28286986
Arch Osteoporos. 2014;9:182
pubmed: 24847682
Maturitas. 2008 Mar 20;59(3):234-41
pubmed: 18343057
J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2 Suppl. 1):103-117. XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana
pubmed: 31169010
Exp Gerontol. 2020 Sep;138:110974
pubmed: 32464171
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):151-6
pubmed: 26604941
Health Policy. 2006 Feb;75(3):329-37
pubmed: 15946761
Osteoporos Int. 2009 Sep;20(9):1507-15
pubmed: 19189165
Osteoporos Int. 2013 Jul;24(7):1973-9
pubmed: 23340948
Int J Environ Res Public Health. 2019 Jul 02;16(13):
pubmed: 31269706
Osteoporos Int. 2012 Mar;23(3):949-55
pubmed: 21594756
Caspian J Intern Med. 2012 Winter;3(1):347-53
pubmed: 26557284
J Midlife Health. 2011 Jul;2(2):81-5
pubmed: 22408337
Int J Womens Health. 2013 Jul 19;5:425-30
pubmed: 23901298
Am J Prev Med. 2008 Jul;35(1):47-54
pubmed: 18541176
Bone. 2012 May;50(5):1039-47
pubmed: 22366398
Clin Endocrinol (Oxf). 2011 Mar;74(3):319-24
pubmed: 21114512
Osteoporos Sarcopenia. 2018 Jun;4(2):53-60
pubmed: 30775543
Indian J Endocrinol Metab. 2014 Jul;18(4):449-54
pubmed: 25143898
J Clin Densitom. 2018 Apr - Jun;21(2):200-204
pubmed: 28034588
Joint Bone Spine. 2009 Jul;76(4):394-400
pubmed: 19297229
Arch Osteoporos. 2019 Mar 13;14(1):38
pubmed: 30868338
Niger J Clin Pract. 2017 Dec;20(12):1522-1526
pubmed: 29378980
Jpn J Nurs Sci. 2015 Jul;12(3):232-48
pubmed: 25407117
Arch Osteoporos. 2009 Dec;4(1-2):79-84
pubmed: 20234791
J Korean Med Sci. 2001 Jun;16(3):323-7
pubmed: 11410694
Saudi Med J. 2007 May;28(5):774-7
pubmed: 17457450
Am J Manag Care. 2010 Jun;16(6):427-33
pubmed: 20560686
Ann Palliat Med. 2020 Mar;9(2):231-238
pubmed: 32156135
Clin Rheumatol. 2015 Mar;34(3):523-7
pubmed: 24777470
J Clin Densitom. 2004 Summer;7(2):127-33
pubmed: 15181256
J Res Med Sci. 2013 Sep;18(9):759-66
pubmed: 24381618
BMC Musculoskelet Disord. 2016 Sep 17;17(1):396
pubmed: 27639376
BMC Musculoskelet Disord. 2018 May 14;19(1):144
pubmed: 29759066
Arch Osteoporos. 2020 Feb 28;15(1):31
pubmed: 32112149
J Korean Med Sci. 2017 Feb;32(2):352-356
pubmed: 28049249
Arch Osteoporos. 2018 Nov 17;13(1):129
pubmed: 30448960
J Med Assoc Thai. 2008;91 Suppl 1:S57-62
pubmed: 18672594
Br J Radiol. 2003 Sep;76(909):605-10
pubmed: 14500274
Arch Osteoporos. 2019 Aug 20;14(1):91
pubmed: 31432256
Am J Epidemiol. 2005 May 1;161(9):824-30
pubmed: 15840614
J Bone Miner Res. 2018 Mar;33(3):396-403
pubmed: 29044768
J Med Assoc Thai. 2007 May;90(5):865-9
pubmed: 17596038
Med J Islam Repub Iran. 2018 Nov 11;32:111
pubmed: 30815406
Bone. 1995 Nov;17(5 Suppl):505S-511S
pubmed: 8573428
J Clin Densitom. 2018 Oct - Dec;21(4):517-523
pubmed: 27914693
BMC Public Health. 2016 Oct 3;16(1):1039
pubmed: 27716144
Women Health. 2017 Oct;57(9):1080-1097
pubmed: 27700695
J Bone Miner Res. 2003 Jul;18(7):1254-60
pubmed: 12854835
Clin Rheumatol. 2021 Sep;40(9):3419-3428
pubmed: 32797362
Arch Osteoporos. 2012;7:31-6
pubmed: 23225279
Yonsei Med J. 2014 Jul;55(4):1049-57
pubmed: 24954336
Med J Armed Forces India. 2013 Apr;69(2):168-71
pubmed: 24600092
Sci Rep. 2016 May 04;6:25206
pubmed: 27143609
Med J Islam Repub Iran. 2015 Jul 20;29:238
pubmed: 26793629
Osteoporos Int. 2003 Nov;14(11):929-40
pubmed: 14530908
Biores Open Access. 2017 Jul 01;6(1):85-93
pubmed: 28736691
Glob J Health Sci. 2015 Nov 18;8(7):135-45
pubmed: 26925890
Arch Osteoporos. 2018 Aug 20;13(1):88
pubmed: 30128890
BMC Musculoskelet Disord. 2010 Mar 11;11:48
pubmed: 20222965
J Clin Densitom. 2016 Oct;19(4):471-476
pubmed: 26948141
Int J Mol Sci. 2015 Mar 10;16(3):5452-66
pubmed: 25764158
J Bone Miner Res. 2012 Sep;27(9):1879-86
pubmed: 22532494
Endocr Pract. 2000 Mar-Apr;6(2):127-31
pubmed: 11421527
Int J Endocrinol. 2015;2015:482940
pubmed: 26273298
J Bone Miner Res. 2014 Nov;29(11):2520-6
pubmed: 24771492
Maturitas. 2014 Mar;77(3):282-6
pubmed: 24529318
BMJ Open. 2020 Jun 11;10(6):e036230
pubmed: 32532773
J Korean Med Sci. 2014 Nov;29(11):1514-22
pubmed: 25408583
Arch Osteoporos. 2013;8:136
pubmed: 24113837
Int J Rheum Dis. 2010 Oct;13(4):385-90
pubmed: 21199475
Calcif Tissue Int. 2013 May;92(5):437-43
pubmed: 23334353
Endocrinol Metab (Seoul). 2013 Sep;28(3):180-91
pubmed: 24396677
Medicine (Baltimore). 2017 Oct;96(43):e8294
pubmed: 29068999
J Bone Miner Res. 2019 Oct;34(10):1789-1797
pubmed: 31067339
J Clin Densitom. 2015 Oct-Dec;18(4):519-24
pubmed: 25592395